![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Inotek Pharmaceuticals Acquires GMP Manufacturing Facility in Israel
Inotek Pharmaceuticals Acquires GMP Manufacturing Facility in Israel
May 24, 2005
Inotek Pharmaceuticals Corporation has acquired a 30,000 square foot GMP manufacturing facility in Dimona, Israel. The manufacturing plant provides Inotek with the ability to manufacture drugs for many of the company's ongoing Phase I and Phase II clinical trials, produce pilot-scale quantities of drug for Inotek's ongoing research and development programs, and potentially provide commercial quantities for approved drugs targeting orphan drug indications.
()a href="http://feeds.bignewsnetwork.com/redir.php?jid=7843707cd5dd6b02&cat=6dcd932030878143" target="_blank">Big News Network
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct